C
Edwards Lifesciences Corporation EW
$81.05 -$0.78-0.95% NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -6.93% -7.16% -87.44% 738.33% 4.09%
Total Depreciation and Amortization 4.10% -14.08% 23.48% -12.88% 2.86%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 1,029.11% 108.53% 97.31% -36,464.89% -186.24%
Change in Net Operating Assets -39.48% 73.63% -167.74% 2,834.40% 94.50%
Cash from Operations 3.50% 319.92% -136.24% -5.30% 794.39%
Capital Expenditure 11.96% -12.45% 4.05% 39.23% -30.78%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- 60.95% -- --
Divestitures -- -- -100.00% -- --
Other Investing Activities -186.91% 161.78% 44.25% -295.15% 63.71%
Cash from Investing -301.76% 114.79% -121.35% 2,064.82% 97.78%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 103.81% 74.48% -17.10% -36.46% -12.56%
Repurchase of Common Stock -- -308,500.00% 99.99% -533.14% -78,950.00%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -7,100.00% 600.00% 100.98% -241.67% 3,700.00%
Cash from Financing 120.43% -1,002.10% 102.93% -911.08% -256.56%
Foreign Exchange rate Adjustments -67.23% -134.71% 199.03% -275.17% 203.09%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 56.89% 114.41% -130.84% 371.99% 429.75%